Laird Norton Wetherby Wealth Management’s Salarius Pharmaceuticals SLRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-13
| Closed | -$8K | – | 934 |
|
2022
Q3 | $8K | Hold |
13
| – | – | ﹤0.01% | 871 |
|
2022
Q2 | $8K | Hold |
13
| – | – | ﹤0.01% | 892 |
|
2022
Q1 | $16K | Hold |
13
| – | – | ﹤0.01% | 911 |
|
2021
Q4 | $20K | Hold |
13
| – | – | ﹤0.01% | 908 |
|
2021
Q3 | $41K | Hold |
13
| – | – | ﹤0.01% | 900 |
|
2021
Q2 | $42K | Hold |
13
| – | – | ﹤0.01% | 904 |
|
2021
Q1 | $59K | Hold |
13
| – | – | ﹤0.01% | 779 |
|
2020
Q4 | $36K | Hold |
13
| – | – | ﹤0.01% | 872 |
|
2020
Q3 | $34K | Hold |
13
| – | – | ﹤0.01% | 717 |
|
2020
Q2 | $52K | Hold |
13
| – | – | ﹤0.01% | 708 |
|
2020
Q1 | $27K | Hold |
13
| – | – | ﹤0.01% | 676 |
|
2019
Q4 | $150K | Sell |
13
-4
| -24% | -$46.2K | 0.01% | 681 |
|
2019
Q3 | $271K | Buy |
+17
| New | +$271K | 0.03% | 576 |
|